CNS Pharmaceuticals Inc (CNSP)

0.116 +0.01 (+4.60%) USD  |  NASDAQ  |  Jan 08, 16:00
0.112 0.00 (0.00%) After-Hours: 20:00
More

CNS Pharmaceuticals Research and Development Expense (Annual): 14.10M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CNSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Ligand Pharmaceuticals Inc 24.54M
Cellectar Biosciences Inc 27.27M
Revance Therapeutics Inc 79.41M
Zymeworks Inc 143.62M
NovaBay Pharmaceuticals Inc 0.068M